AMMI Canada position statement: The use of early antiretroviral therapy in HIV-infected persons

Author:

Becker M1,Cox J2,Evans GA3,Haider S4,Shafran SD5

Affiliation:

1. Departments of Medicine, Medical Microbiology and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

2. Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, Québec, Canada

3. Division of Infectious Diseases, Department of Medicine, Queen’s University, Kingston, Ontario, Canada

4. Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada

5. Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Publisher

University of Toronto Press Inc. (UTPress)

Subject

Infectious Diseases,Microbiology (medical)

Reference92 articles.

1. Churchill D; on behalf of the BHIVA Treatment Guidelines Writing Group. British HIV Association guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2015. (Accessed October 20, 2015).

2. Abrams E; on behalf of the WHO Clinical Guideline Development Group. WHO guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, September 2015. (Accessed October 20, 2015).

3. Gulick RM; on behalf of the Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents. Statement by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents Regarding Results from the START and TEMPRANO trials, July 28, 2015. (Accessed October 20, 2015).

4. Lundgren JD; on behalf of the Panel of the EACS (European AIDS Clinical Society). EACS Guidelines Version 8, October 2015. (Accessed October 20, 2015).

5. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. (Accessed February 12, 2016).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3